Loading…
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis
Autoreactive, myelin-specific, CD4+ T cells have a central role in multiple sclerosis (MS) pathogenesis; however the exact phenotype characteristics of these cells remain elusive. Recently, granulocyte-macrophage colony-stimulating factor (GM-CSF) expression has emerged as the main pathological sign...
Saved in:
Published in: | Journal of neuroimmunology 2018-10, Vol.323, p.1-9 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Autoreactive, myelin-specific, CD4+ T cells have a central role in multiple sclerosis (MS) pathogenesis; however the exact phenotype characteristics of these cells remain elusive. Recently, granulocyte-macrophage colony-stimulating factor (GM-CSF) expression has emerged as the main pathological signature of the encephalogenicity in both T and B cell compartment. In this review we have summarized the current data supporting GM-CSF relevance in MS pathophysiology, in the context of both immunomodulatory and neuroinflammatory processes; as well as the potential cellular sources of this stimulating factor, including different T and B cell subsets.
[Display omitted]
•GM-CSF emerged as the main pathological signature of T and B cells in MS.•GM-CSF is implicated in configuring main MS pathological features.•GM-CSF could be important from the aspect of self-tolerance breakdown.•GM-CSF was initially attributed to Th17 cells; however other sources are also speculated. |
---|---|
ISSN: | 0165-5728 1872-8421 |
DOI: | 10.1016/j.jneuroim.2018.07.002 |